Studies were conducted with rats to investigate whether exposure to carbon monoxide (CO) at concentrations frequently found in the environment caused lung injury mediated by nitric oxide ( • NO)-derived oxidants. Lung capillary leakage was significantly increased 18 h after rats had been exposed to CO at concentrations of 50 ppm or more for 1 h. An elevation of
Ambient carbon monoxide (CO) 1 levels in air pollution have been correlated with hospital admissions, mortality, and morbidity due to cardiovascular and respiratory diseases (Kinney and Ozkaynak, 1991; Morris et al., 1995) . CO is a cellular asphyxiant due to its high affinity for hemoproteins, but this may not be the only pathophysiological mechanism. When vascular endothelial cells in culture are exposed to between 20 and 100 ppm CO, they suffer oxidative stress and a form of delayed death due to generation of nitric oxide (
• NO)-derived oxidants (Thom et al., 1997) . Both endothelial cells and platelets have been found to liberate
• NO to the surrounding medium when exposed to CO. These effects occur because CO increases the intracellular steady-state concentration of
• NO by inhibiting
• NO binding to hemoproteins, without changing the activity of nitric oxide synthase or mitochondrial function (Thom et al., 1994a (Thom et al., , 1997 .
When human beings or experimental animals have been exposed to relatively low CO concentrations for hours at a time, leakage of macromolecules from the lung and systemic vasculature was documented but the presence of an hypoxic stress was questioned (Kjeldsen et al., 1972; Maurer, 1941; Parving et al., 1972; Siggaard-Anderson et al., 1968) . In contrast, when animals have been exposed to high CO concentrations, usually for only brief periods of time due to the occurrence of an hypoxic stress with carboxyhemoglobin (COHb) levels of 56 to 90%, alterations in lung physiology were not detected (Fisher et al., 1969; Robinson et al., 1985; Shimazu et al., 1990; Sugi et al., 1990) and evidence of increased capillary permeability was inconsistent (Niden and Schulz, 1965; Fein et al., 1980; Halebian et al., 1984; Penney et al., 1988) .
CO is a ubiquitous environmental pollutant. Automobile emissions are the primary source of outdoor CO. Urban atmospheric CO levels in the United States now vary from approximately 2 to 40 ppm, but in areas of the world where catalytic converters are infrequently used the CO levels may be as high as 170 ppm next to busy streets and in underpasses (EPA, 1991; Wright et al., 1975) . Cigarette smoke, a frequently cited source of indoor CO, contains levels in mainstream and sidestream smoke ranging from approximately 35 to 1000 ppm (Wald and Howard, 1975) . Smokers and workers in some occupational settings have elevated COHb levels in the range of 3 to 11% (Radford and Drizd, 1982) .
We hypothesized that rats exposed to concentrations of CO frequently found in contaminated environments would exhibit evidence of pulmonary vascular oxidative injury and that this injury would be mediated by
• NO-derived oxidants. As discussed above, published results have been controversial re-garding whether CO exposure causes a vascular leak. Because some effects of CO on endothelial cells occur in a delayed fashion (Thom et al., 1997) , we reasoned that detection of injury might depend upon the time when measurements were made. In this paper we investigated leakage of radioactive albumin into lung parenchyma over a 2-day period after CO exposures. Electron paramagnetic resonance (EPR) spectroscopy was used to directly evaluate whether CO exposure increased
• NO concentration in lung. We were also interested in whether reactive oxygen species were increased in association with CO exposure. There are few techniques to evaluate this process in the living animal. Dismutation of superoxide radical (O 2 •Ϫ ) will generate H 2 O 2 and one method for assessing production of H 2 O 2 in the intact animal is by administration of 3-amino-1,2,4-triazole (ATZ). Intraperitoneal injection of ATZ in rats causes irreversible inhibition of catalase. Catalase is inactivated only in the presence of H 2 O 2 because ATZ reacts with the catalase intermediate, Compound I, forming an inactive covalent complex with the protein. ATZ administration has been used to evaluate H 2 O 2 production in brains of rats (Piantadosi and Tatro, 1990; Sinet et al., 1980; Yusa et al., 1987) . ATZ administration has also been shown to inhibit catalase in liver and erythrocytes (Cohen and Hochstein, 1965 ), but we are unaware of previous studies with lungs. One consequence of increasing concentrations of both
• NO and O 2 •Ϫ is production of
• NO-derived oxidants, such as peroxynitrite. Peroxynitrite is a relatively long-lived, strong oxidant that is generated by the near diffusion-limited reaction between
• NO and O 2
•Ϫ (Beckman et al., 1990; Huie and Padjama, 1993) . Evidence for production of • NO-derived oxidants was sought by measuring nitrotyrosine, a major product of the reaction of peroxynitrite with proteins (Ischiropoulos et al., 1992) .
METHODS

Animals and reagents.
Wistar male rats (Charles River Laboratories, Wilmington, MA) weighing 200 to 290 g were fed a standard diet and water ad libitum. [
125 I]-bovine serum albumin (BSA) was purchased from ICN Pharmaceuticals (Irvine, CA). Antibodies against myeloperoxidase were purchased from Dako Corp. (Carpinteria, CA) and antiendothelial nitric oxide synthase and antiinducible nitric oxide synthase were purchased from Affinity BioReagents (Golden, CO). Unless otherwise specified, other reagents were purchased from Sigma Chemical Corp. (St. Louis, MO).
Animal manipulations. Rats were exposed to CO in a 7-liter Plexiglas chamber. A mixture of CO and air was flushed through the chamber at a rate of 8 to 12 liters/min. Premixed gas supplies containing 100 or 1000 ppm CO in air were purchased from Air Products, Inc. (Camden, NJ). When a concentration less that 100 ppm CO was desired, exposure gas was prepared using a gas mixing chamber (Calibrated Instruments Inc., Ardsley, NY). A supply of compressed air containing 100 ppm CO was attached to one port of the device and purified compressed air was attached to the second port. The concentration of CO was selected by setting the mixing ratio between the CO supply and the compressed air, and the concentration delivered was verified using a gas chromatography CO detector (Trace Analytical Reduction Gas Analyzer, Menlo Park, CA).
Circulating polymorphonuclear leukocytes (PMN) were reduced to counts of less that 100 cells/l blood by an injection of 4 ml/kg ip antineutrophil antiserum (Inter-cell Technologies, Hopewell, NJ) administered 24 h before CO exposure studies (Ischiropoulos et al., 1996) . L-nitroarginine methyl ester (L-NAME, 1 mg/kg ip) was injected 2 h before CO exposure.
Analytical procedures. Heparinized blood (10 U/ml) was drawn into a closed system, and blood COHb levels were measured using a CO-oximeter Model 282 (Instrumentation Laboratories, Lexington, MA).
Leakage of [ 125 I]-BSA into lung parenchyma was measured using techniques described in a previous publication (Thom et al., 1994b) . The permeability index was defined as 100ϫ (radioactive counts present in the lung homogenate/radioactive count in 1 ml of blood). Rats were anesthetized by an injection with ketamine (73.5 mg/kg ip) and xylazine (1.5 mg/kg ip). Lungs were perfused with 154 mM NaCl in 0.1 M phosphate buffer, pH 7.4 (PBS) containing 4% Ficoll until they were cleared of blood, blotted, and homogenized in a Polytron blender (Brinkmann Instruments, Rexdale, Ontario, Canada). The homogenate was placed into tubes and counted in a gamma counter (LKB Wallac, Turku, Finland) . Correction for the small amount of blood remaining in the homogenates was made by measuring residual hemoglobin using dithionite according to published procedures (Thom et al., 1994b) .
The nitrotyrosine concentration in lung homogenates was measured using a solid-phase radiochemical assay exactly as described in a previous publication (Ischiropoulos et al., 1996) . EPR measurements of
• NO were carried out following previously published methods (Ohnishi, 1998) . Aminotriazole(ATZ)-dependent inhibition of catalase was assessed following methods outlined by Yusa et al., (1987) . For both EPR and ATZ studies, rats were exposed to 100 ppm CO for 30 min, quickly removed and injected with the appropriate indicator agent, and then replaced in the CO environment for the remainder of the hour-long exposure. Rats for the EPR studies were injected with diethyldithiocarbamate (DETC) (400 mg/kg sc) and, at a different site, with a solution of ferrous sulfate (40 mg/kg)-sodium citrate (200 mg/kg). For catalase inhibition studies, rats were injected with ATZ (1 g/kg ip). The injection procedure for these studies was necessary because preliminary investigations established that the concentrations of both DETC and ATZ in lungs increased rapidly, but then dropped after 30 min. At the end of the CO exposures rats were anesthetized and killed by exsanguination. For EPR studies, lungs were excised, extruded through a 3-ml syringe into quartz EPR tubing (4 mm od), and frozen in liquid nitrogen. EPR spectra were recorded using a Varian E-109 spectrometer of the Department of Biochemistry and Biophysics, University of Pennsylvania. The conditions for EPR measurements were 20 mW microwave power, 4 ϫ 10 4 gain (and doubled to 8 ϫ 10 4 where indicated), 0.2 mT modulation, 9.10 GHz microwave frequency, 100 KHz modulation frequency, scan range 10 mT, scan time constant 0.25 s, scan time 4 min. Two scans were made for each sample and the signal was averaged. Temperature for the EPR measurement was Ϫ150°C.
For the ATZ studies, lungs were perfused to clear residual blood with PBS containing 4% Ficoll, weighed, and homogenized using a Polytron blender in 50 mM potassium phosphate, 0.1 mM EDTA, and 0.1% (v/v) Triton X-100 (pH 7.0). The volume of buffer used was 5 ml/g of lung. An aliquot of homogenate was set aside for measurement of ATZ concentration and the remainder was centrifuged at 700g for 20 min at 4°C. Catalase activity in the supernatents were assayed at 25°C by the method of Aebi (1974) based on the disappearance of 10 mM H 2 O 2 at 240 nm in a preparation containing 50 mM potassium phosphate and 0.1 mM EDTA (pH 7.0). Catalase activity present in blood from each rat was also determined, as was the amount of residual blood in the lung homogenate using dithionite following methods previously described (Thom et al., 1994b) . The lung catalase activity was expressed as the decrease in absorbance at 240 nm/min/g lung after the appropriate correction was made for the catalase activity associated with the blood remaining in the lung homogenates. The concentration of ATZ in lung homogenates was measured colorimetrically following the method of Green and Feinstein (1957) . In brief, lung homogenate (1 ml) was combined with 1 ml 1 M trichloroacetic acid, to which was added 2 mM sodium nitrite and 0.5 mM 4,5 dihydroxynaphthalene-2,7-disulfonic acid. The mixture was heated to 100°C for 2.5 min and the diazotization reaction was stopped by addition of 20 mM urea. After centrifugation at 700g for 10 min, optical absorbance of the solution at 525 nm was measured and corrected for residual turbidity by measuring absorbance at 630 nm. The concentration of ATZ was determined using a standard curve.
Myeloperoxidase concentration in lungs was measured using a new radiochemical assay. Tissue was perfused to remove blood as outlined above, and then lungs were removed and immediately frozen in liquid nitrogen. The frozen tissue was weighed and placed in 2 ml PBS/g of tissue. These samples were homogenized with a Polytron, subjected to two freeze-thaw cycles with liquid nitrogen, and then made to 1% (w/v) cetyltrimethylammonium bromide (CTAB). Control experiments were also done using isolated rat PMN that had been obtained from heparinized blood by density gradient centrifugation using materials and procedures from Cardinal Associates, Inc. (Santa Fe, NM). This process resulted in suspensions of rat PMN that exceeded 95% purity. Suspensions of PMN in 1 ml PBS were subjected to the same freeze-thaw procedures as the tissue samples and suspended in 2 ml of CTAB solution. Homogenized samples of tissue or PMN were centrifuged at 1000g for 10 min, supernatents were made up to a volume of 10 ml with 1% CTAB containing 1 mM CaCl 2 , MnCl 2 , and MgCl 2
•, and then passed through 0.45-m polycarbonate filters. Filtered samples were placed in test tubes with 0.5 ml Concanavalin A gel and incubated overnight at 4°C with constant shaking. The samples were then centrifuged at 1000g for 5 min and the pellet was washed twice with wash buffer (0.1 M sodium acetate [pH 6.0], containing 0.1 M NaCl and 0.05% [w/v] CTAB). The washed pellets were resuspended in 300 l elution buffer (wash buffer that contained 0.5 M methyl ␣-D-mannopyranoside), incubated for 10 min, and centrifuged at 1000g for 5 min. The supernatant was saved and the pellet was subjected to two additional washes with elution buffer. All supernatents were combined (900 l) and frozen at Ϫ20°C until analysis. Proteins in the Concanavalin A eluates were immobilized by spotting from four to eight concentration-dependent dilutions of the tissue extracts onto nitrocellulose paper using the 96-well Bio-Dot microfiltration unit (BioRad, Hercules, CA). Human myeloperoxidase (Sigma Chemical Corp) was prepared in PBS and eight to 12 different concentrations were also placed onto the same paper. After blocking with 2% gelatin, the nitrocellulose was incubated for 15 h with a solution containing 1:100 dilution rabbit anti-human myeloperoxidase followed by a 3 h incubation in a solution containing donkey anti-rabbit [
125 I]-labeled IgG (0.1-0.2 mCi/ml). The blot was extensively washed in 0.5% Tween-20 and 20 mM Tris-HCl, 500 mM NaCl (pH 7.5) (Tween-TBS)-followed by drying. The radioactivity of each sample was measured directly by Beta scanning using an Ambis 400 imaging detector. The net counts of radioactivity (corrected for background counts from a sample blank) were obtained using the AMBIS image analysis software v4.1 and then plotted on a semilogarithmic plot. The counts obtained with human myeloperoxidase were used to assure that the technique for individual experiments were comparable. The data, recorded as cpm, were converted to number of rat PMN using a relationship generated in preliminary trials in which we correlated [
125 I] cpm obtained with extracts prepared using different numbers of PMN. The semilogarithmic plot was subjected to analysis by least squares linear regression (n ϭ 20), r 2 ϭ 0.88. Neutrophil sequestration in lungs was expressed as the number of cells derived from the semilogarithmic plot per mg of lung tissue in the original homogenate.
Western analysis was performed after lungs were homogenized in 0.1 M PBS containing 2 mM MgCl 2 after clearing residual blood, as described above for [
125 I]-BSA leakage. The preparation was diluted to a concentration of 100 g protein/10 l in 0.1 M PBS containing 2% SDS, 10% glycerol, 5% ␤-mercaptoethanol, and 0.00125% bromophenol blue and boiled for 5 min. Equal amounts of preparation from different lung homogenates (100 g) were subjected to 12% SDS-PAGE and proteins were transferred to 0.45 m polyvinylidene difluoride membrane (PVDF, Bio-Rad). Membranes were incubated for 2 h with PBS containing 0.1% Tween-20 and 5% nonfat dry milk and then for 2 h with either rabbit antiendothelial, or antiinducible nitric oxide synthase (1:1000 dilution). Membranes were washed with Tween-TBS incubated for 3 h with horseradish peroxidase-conjugated anti-rabbit IgG (1:3000 dilution from Boehringer Mannheim Inc., Ridgefield, CT) and washed again for 25 min with Tween-TBS. Imaging of the membranes was carried out by enhanced chemiluminescence (ECL) using ECL reagents and procedures obtained from Amersham Life Sciences on Kodak Reflection Film (Eastman Kodak, Rochester, NY). The film was developed and scanned on a Microtek Scanmaker E6 (Redondo Beach, CA) with transparency adaptor and analyzed using SigmaScan (Jandel Corp., Chicago, IL).
Statistics. Statistical analysis was determined by analysis of variance followed by Scheffe's test (Snedecor and Cochran, 1980) . The level of significance was p Ͻ 0.05. Results are expressed as means Ϯ SE.
RESULTS
Pulmonary Vascular Leak
Evidence for vascular injury was sought by measuring the leakage of radioactive albumin into lung parenchyma after rats had been exposed to CO for 30 min or 1 h. The time course of the leakage, shown in Fig. 1 , demonstrates a significant increase 18 h after rats had been exposed to 100 ppm CO and resolution of the leakage by 48 h. If rats were exposed to 100 ppm CO for only 30 min, no leakage was detected 18 h later (data not shown). There were no gross structural changes in lungs on standard histological sections taken from rats at any time after CO exposure.
The possible role for • NO in lung injury was first investigated by assessing CO-induced vascular leakage after rats were injected with a competitive inhibitor of nitric oxide synthase, L-NAME. No significant leakage of radioactive albumin occurred after exposure to 100 ppm CO for 1 h when rats were pretreated with L-NAME. The permeability index was 8.7 Ϯ 0.4% (n ϭ 6), virtually identical to control (8.6 Ϯ 0.5%, n ϭ
FIG. 1. Time course for permeability of lungs to [
125 I]-BSA. Values reflect the permeability index for lungs of rats exposed for 1 h to 100 ppm CO and killed at the times indicated or rats housed in the same room as the CO groups but who breathed only air (control). Values are means Ϯ SE. n, number of rats studies in each group. *Significantly greater than control. 31) but significantly less than rats exposed to 100 ppm CO (16.8 Ϯ 1.8%, n ϭ 11), as shown in Fig. 1 . If rats were treated with D-NAME, the stereoisomer of L-NAME that does not inhibit nitric oxide synthase, no reduction in 100 ppm COmediated lung leak occurred as the permeability index in these rats was 19.5 Ϯ 2.0% (n ϭ 3).
We examined the effect of exposure to CO at concentrations between 20 and 1000 ppm. Vascular leakage was increased after exposure to 50 ppm CO or more (Fig. 2 ). There were no significant differences in leakage following exposures to 50, 100, or 1000 ppm CO, although the exposures resulted in significantly different COHb levels. Control rats had a COHb concentration of 0.9 Ϯ 0.2% (SE, n ϭ 17). The concentration of COHb immediately after 50 ppm CO was 4.8 Ϯ 0.6% (n ϭ 8, NS vs control), after 100 ppm CO it was 10.6 Ϯ 0.8% (n ϭ 7, p Ͻ 0.05 vs control and vs 50 ppm CO groups), and after 1000 ppm CO it was 53.7 Ϯ 0.9% (n ϭ 14, p Ͻ 0.05 vs all other groups).
Detection of • NO in Lung During CO Exposure by EPR
Rats were exposed to 100 ppm CO for 1 h and the presence of • NO in lungs was evaluated by EPR. A triplet • NO signal, characteristic for the • NO-iron-DETC adduct (Tominaga et al., 1994) , was found in the lungs of rats at the end of the CO exposure. Figure 3 exhibits typical spectra. The concentration of
• NO can be related to the distance between the peak at g ϭ 2.047 and trough at g ϭ 2.027 (Tominaga et al., 1994) . The distances between these points, identified by horizontal lines in Fig. 3, averaged 3 .2 Ϯ 0.9 (n ϭ 3) after CO exposure and 1.2 Ϯ 0.3 (p Ͻ 0.05, n ϭ 3) for control rats. This indicates that the lung • NO level in CO-exposed rats was approximately 2.6 times greater than in control rats. The triplet • NO signal was clearly seen in the difference spectrum for CO-exposed rats vs CO-exposed rats pretreated with L-NAME (spectrum "d" in Fig. 3 ). If CO-exposed rats were injected with DETC and iron at the end of the CO exposure, and left to breathe air for 30 min before lungs were taken, the EPR spectrum was the same as control. This indicates that the CO-mediated elevation in
• NO concentration was a transient effect.
Elevation in Lung H 2 O 2 during CO Exposure
We were interested in whether reactive oxygen species were increased in association with CO exposure. The specific question addressed was whether the concentration of H 2 O 2 was increased in lungs of CO-exposed rats. This was assessed by measuring catalase inactivation following an ip injection of ATZ (see Methods).
FIG. 3. EPR spectra of rat lungs. The concentration of
• NO is taken as the differences between signals at g ϭ 2.047 and g ϭ 2.027 (identified by horizontal lines) for a CO-exposed rat (a), a control rat (b), and a rat pretreated with L-NAME prior to CO exposure (c). The difference spectrum for (COexposed [a]) vs (L-NAME ϩ CO-exposed [c]) lung is shown in d and the spectrum for (control [b] vs (L-NAME ϩ CO-exposed [c] ) is shown in e. Note that the two difference spectra were magnified twofold to more clearly illustrate the triplet
• NO-iron-DETC spectrum.
FIG. 2. CO dose-response for permeability of lungs to [
125 I]-BSA. Values reflect the permeability index for lungs 18 h after rats were exposed for 1 h to either 20, 50, 100, or 1000 ppm CO or rats housed in the same room as the CO groups but who breathed only air (control). There are no significant differences among the groups exposed to 50, 100, or 1000 ppm CO. Values are means Ϯ SE. n, number of rats studies in each group. *Significantly greater than control.
Exposure to CO, in the absence of ATZ, did not alter the catalase concentration in rat lungs. This is shown by identical values for catalase activity in lung homogenates from control and CO-exposed rats at Time 0 in Fig. 4 . The observation demonstrates that the increased • NO, made available during CO exposure, did not inhibit catalase as has been shown by others (Farias-Eisner et al., 1996) . However, if ATZ was present in rats for 30 min, there was significantly less catalase activity in lungs of both control and CO-exposed rats. Further, lung catalase activity was significantly lower in rats that had breathed CO vs only air (Fig. 4) . When rats were injected with L-NAME prior to breathing CO, the effect of CO exposure on catalase activity was no longer present. To confirm that ATZ was indeed acting on the catalase-H 2 O 2 intermediate, Compound I, studies were conducted with rats injected with ethanol (4 g/kg ip) prior to CO exposure. Ethanol rapidly reduces Compound I, thereby competing with ATZ and preventing catalase inhibition. As shown in Fig. 4 , ethanol negated the effect of ATZ so that catalase activity was the same as in samples at Time 0. When interpreting these results it is also important to know that peroxynitrite will not react with catalase to form Compound I (Floris et al., 1993) . From this series of studies we conclude that the augmented catalase inhibition seen in the CO-exposed samples was due to an elevated concentration of H 2 O 2 in the lungs and that this CO-mediated effect was dependent on
• NO.
The concentration of ATZ in the lungs of control rats 30 min after ATZ was injected was 35.0 Ϯ 6.9 g ATZ/g lung (SE, n ϭ 5) and, in lungs from CO-exposed rats, it was 37.9 Ϯ 5.3 (n ϭ 6, no significant difference). However, whereas the ATZ concentration in brain has been reported to rise for 2 h after ip injection (Yusa et al., 1987) , the content of ATZ in lungs decreased rapidly after ip administration. In rats killed just 10 min after ATZ injection, the concentration in lungs was 58.6 Ϯ 8.3 g ATZ/g lung (n ϭ 5), significantly greater than at 30 min. Because the lung ATZ concentration decreased so rapidly, we do not believe that the ATZ method can be used for quantitative estimations of in situ H 2 O 2 concentration. However, the results offer qualitative evidence that exposure to CO caused an elevation of reactive oxygen species by an
• NOdependent process.
Lung Nitrotyrosine Concentration
Tyrosine nitration was assayed as an index for production of peroxynitrite in response to CO exposure. Nitrotyrosine concentration was significantly increased for several hours after exposure to 100 ppm CO, and this was not observed if rats were pre-treated with L-NAME (Fig. 5) .
Lung Concentration of Nitric Oxide Synthase (NOS)
Analysis of lung homogenates for the concentration of NOS was performed on Western blots (Fig. 6) . The concentration of NOS in lung tissue was evaluated by comparing the density of the bands obtained using homogenates from CO-exposed rats FIG. 5. Nitrotyrosine concentration in lung homogenates. Rats were exposed to 100 ppm CO for 1 h and, at the times indicated, were anesthetized and lungs were obtained. Where indicated, rats were injected with L-NAME. Values are means Ϯ SE. *Significantly greater than control, CO-immediate, and CO-2 hours ϩ L-NAME. There are no significant differences among the three CO-exposed groups killed 2, 3, or 4 h after exposure.
FIG. 4.
Catalase activity in lung homogenates in association with administration of (ATZ). Values indicate catalase activity in samples from airexposed (control) rats and rats exposed to 100 ppm CO for 1 h. Catalase activities in the absence of ATZ are shown by the bars labeled "0 minutes." The activities in rats killed 30 min after injection of 1 g/kg ip ATZ are shown by bars labeled "30 minutes." CO-exposed rats had ATZ injected 30 min prior to termination of the exposure. Where indicated, rats were pretreated with L-NAME (1 mg/kg ip) 2 h prior to CO exposure or with ethanol (ETOH) (4 g/kg ip) just before CO exposure. All values are means Ϯ SE. n, number of rats studied in each group. *Significantly less than control. ϩSignificantly less than all other samples.
with the mean density for bands from control rats run on the same gel. As summarized in Table 1 , there were no significant changes in endothelial or inducible NOS as a result of CO exposure.
Role of Leukocytes in Vascular Injury
Circulating leukocytes play a role in causing microvascular damage after some insults. Nitric oxide can protect against leukocyte-mediated injury by inhibiting leukocyte-endothelial cell adhesion (Aoki et al., 1990; Kurose et al., 1994; Guidot et al., 1995) , but
• NO may also participate in free radical-mediated vascular injury under some circumstances (Ischiropoulos et al., 1994; Mulligan et al., 1991) . Nitrotyrosine can also be generated by circulating PMN or by myeloperoxidase/H 2 O 2 and nitrite (Evans et al., 1996; van der Vliet et al., 1997) . Because of these issues, we assessed leukocyte sequestration in lungs by measuring myeloperoxidase concentration. There was no significant increase after rats had been exposed to 100 ppm CO. Based on the solid-phase radioimmunoassay (see Methods), lungs from control rats had 4690 Ϯ 180 (n ϭ 9) leukocytes/mg lung tissue. Immediately after exposure to CO lungs had 4850 Ϯ 50 (n ϭ 3, not significant vs control) leukocytes/mg and 18 h after exposure there were 5260 Ϯ 170 leukocytes/mg lung (n ϭ 6, not significant vs control). Rats treated with L-NAME before exposure to 100 ppm CO and then killed 18 h later had 4360 Ϯ 80 neutrophils/mg lung (n ϭ 3, not significant vs control).
We investigated whether circulating PMN were involved in development of CO-mediated lung vascular permeability by measuring radioactive albumin leakage in neutropenic rats.
The permeability index was 13.8 Ϯ 1.1% (n ϭ 3, p Ͻ 0.05 vs control) at 18 h after neutropenic rats were exposed to 100 ppm CO. This value was not significantly different from leakage measured in rats exposed to 100 ppm CO that were not neutropenic (14.5 Ϯ 1.8%, n ϭ 9, see Fig. 1 ).
DISCUSSION
The results from this study demonstrate that exposure to CO at concentrations found in modern environments cause pulmonary vascular injury. Based on the inhibitory effect of L-NAME, development of the vascular leak is an
• NO-dependent process. EPR spectroscopy indicates that exposure to CO causes an increase of • NO in lungs. Western blots demonstrate that CO does not alter the concentration of NOS. The most likely mechanism for the increase in • NO signal is competition for hemoprotein targets between CO and the • NO that is normally produced in lungs. This is the mechanism we have identified in studies with endothelial cells and platelets (Thom et al., 1994a (Thom et al., , 1997 . We cannot rule out the possibility that CO may increase the activity of nitric oxide synthase in the intact lung. However, we have shown that CO at concentrations used in this study do not alter NOS activity in endothelial cells or platelets (Thom et al., 1994a (Thom et al., , 1997 . Moreover, at higher concentrations, CO will inhibit, not enhance, NOS activity (Thom et al., 1994a; White, 1992) . Exposure to CO increases lung H 2 O 2 concentration by an • NO-dependent process. One possible mechanism is that • NO or peroxynitrite may perturb mitochondrial function. Peroxynitrite appears to inhibit complexes I-III and
• NO targets cytochrome oxidase (Cassina and Radi, 1996; Lizasoain et al., 1996; Poderoso et al., 1996) . We did not find alterations in mitochondrial function or an increase of cellular H 2 O 2 when endothelial cells were exposed to CO in vitro (Thom et al., 1997) . It is possible, of course, that with in vitro passage cultured cells become less dependent on oxidative metabolism, and therefore less sensitive to mitochondrial perturbations, compared with cells that remain in vivo. Alternatively, exposure to CO may inhibit lung antioxidant defenses. Mechanisms linked to elevations in • NO could be responsible for inhibiting one or more enzymes. Nitric oxide-derived oxidants can inhibit manganese superoxide dismutase, glyceraldehyde-3-phosphate dehydrogenase, and deplete cellular stores of reduced glutathione (Ischiropoulos et al., 1992; Luperchio et al., 1996) .
FIG. 6.
Western blot of lung homogenates. Tissue homogenates were subjected to PAGE and processed as described in Methods. Samples were taken from control rats or from rats exposed to 100 ppm CO for 1 h.
TABLE 1 Nitric Oxide Synthase Content in Lung Homogenates
Endothelial NOS Inducible NOS Control (n ϭ 9) 1.00 Ϯ 0.06 1.02 Ϯ 0.05 2 h post-100 ppm CO (n ϭ 7)
1.02 Ϯ 0.09 1.07 Ϯ 0.09 18 h post-100 ppm CO (n ϭ 8) 1.13 Ϯ 0.06 0.90 Ϯ 0.05
Note. Western blots of lung homogenates were quantitatively evaluated using enhanced chemiluminescent techniques (see Methods). Values in the table were derived by dividing the measured density of individual bands with the mean band density for control samples run on same gels. Data are means (ϮSE) and no values are significantly different from control.
Production of
• NO-derived oxidants in association with CO exposure was documented by an elevation in lung nitrotyrosine. Nitrotyrosine remained elevated for only a few hours after CO exposure, suggesting that the modified peptides were promptly degraded. It is unclear whether
• NO or • NO-derived oxidants were directly responsible for development of the vascular leak. An inflammatory response is an alternative possible mechanism for the vascular injury associated with CO exposure. Our studies indicate, however, that leukocyte sequestration did not occur in response to CO exposure and neutropenia did not alter the development of the vascular leak. We conclude that leukocytes extrinsic to the lungs do not play a role in CO-mediated lung injury, but current information does not allow identification of the roles for cell types intrinsic to the lungs.
Vascular leakage due to CO has been documented in a number of studies that involved exposures of many hours (Kjeldsen et al., 1972; Maurer, 1941; Parving et al., 1972; Siggaard-Anderson et al., 1968) . Other investigators have sought evidence of physiological alterations in lungs after brief exposures between 5 and 45 min (Fisher et al., 1969; Robinson et al., 1985; Shimazu et al., 1990; Sugi et al., 1990) . No significant lung alterations were documented except for a transient increase of lung vascular permeability in one sheep study between 1 and 4 h after an 8-min-long exposure to 2% CO (Sugi et al., 1990) . Our results indicate that development of a vascular leak is influenced by the duration of CO exposure and also the time following exposure.
The temporal order of events leading to the pulmonary vascular leak in rats 18 h after exposure to CO is obviously complex. One possible scenario is as follows: (1) COmediated competition with
• NO for binding sites, which causes an increased steady-state
• NO concentration. (2) Increased production of
• NO-derived oxidants by reactions between
• NO, which is at a higher concentration, and O 2 •Ϫ , which is at its normal steady-state concentration due to aerobic metabolism. (3) An apparent increase in reactive oxygen species either by
• NO-or peroxynitrite-mediated perturbations of mitochondria, or inhibition of antioxidant defenses. (4) A slowly evolving alteration of lung physiology that may be due to persistent inhibition of mitochondria, antioxidants, antiproteases (some are known to be inhibited by peroxynitrite; Moreno and Pryor, 1992) , or other endothelial perturbations such as delayed death. (5) Recovery from the acute lung injury within 48 h.
The long-term physiological stress associated with the lung vascular leakage, as found in our studies, is unclear. Clearly, additional studies are necessary to evaluate this question and to elucidate the biochemical mechanisms. If these phenomena occur in humans, the impact of repetitive insults as would occur with occupational exposures and smoking must also be investigated.
